ESCITALOPRAM
Drug
H. Lundbeck A S
Total Payments
$29,900
Transactions
14
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $27,169 | 12 | 1 |
| 2018 | $2,731 | 2 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $16,738 | 4 | 56.0% |
| Travel and Lodging | $12,826 | 8 | 42.9% |
| Food and Beverage | $336.43 | 2 | 1.1% |
Ad
Manufacturing Companies
- H. Lundbeck A S $29,900
Product Information
- Type Drug
- Total Payments $29,900
- Total Doctors 2
- Transactions 14
About ESCITALOPRAM
ESCITALOPRAM is a drug associated with $29,900 in payments to 2 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is H. Lundbeck A S.
Payment data is available from 2018 to 2024. In 2024, $27,169 was paid across 12 transactions to 1 doctors.
The most common payment nature for ESCITALOPRAM is "Honoraria" ($16,738, 56.0% of total).